COVID-19 rapid molecular point-of-care testing is effective and cost-beneficial for the acute care of trauma patients

PURPOSE: To evaluate the accuracy and cost benefit of a rapid molecular point-of-care testing (POCT) device detecting COVID-19 within a traumatological emergency department. BACKGROUND: Despite continuous withdrawal of COVID-19 restrictions, hospitals will remain particularly vulnerable to local out...

Descripción completa

Detalles Bibliográficos
Autores principales: Stolberg-Stolberg, Josef, Jacob, Elena, Kuehn, Joachim, Hennies, Marc, Hafezi, Wali, Freistuehler, Moritz, Koeppe, Jeanette, Friedrich, Alex W., Katthagen, J. Christoph, Raschke, Michael J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447950/
https://www.ncbi.nlm.nih.gov/pubmed/36066585
http://dx.doi.org/10.1007/s00068-022-02091-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9447950/
https://www.ncbi.nlm.nih.gov/pubmed/36066585
http://dx.doi.org/10.1007/s00068-022-02091-x

Ejemplares similares